Sunshine Biopharma, Inc. (SBFM) News
Track canonical SquawkNews coverage tagged to SBFM, Sunshine Biopharma, Inc.. This hub brings together deduplicated headlines about alpaca us equities, markets catalysts, earnings, analyst actions, and wider market events so traders can review how a developing story changed over time. It contains 5 indexed stories across 4 publication days and is ordered by the same first-publication timeline used by LiveCast.
L
SBFM - Sunshine Biopharma Enters the $2.8 Billion Global Dienogest Market with Canadian Regulatory Approval
SBFM - Sunshine Biopharma Enters the $2.8 Billion Global Dienogest Market with Canadian Regulatory Approval
EQUITY | Aug 04, 2026, 01:00 PM UTC
L
SBFM - Health Canada Approves Sunshine Biopharma's Ondansetron for Treatment of Chemotherapy-Induced Nausea and Vomiting
SBFM - Health Canada Approves Sunshine Biopharma's Ondansetron for Treatment of Chemotherapy-Induced Nausea and Vomiting
EQUITY | Jul 28, 2026, 12:00 PM UTC
L
SBFM Sunshine Biopharma - enters at-the-market sales agreement with aegis capital for up to $4M - SEC filing
SBFM Sunshine Biopharma - enters at-the-market sales agreement with aegis capital for up to $4M - SEC filing
REGULATION | Jul 20, 2026, 08:29 PM UTC
M
SBFM Gets Canada Approval
Sunshine Biopharma announces approval of generic Anastrozole tablets for Canadian market
EQUITY | Jun 25, 2026, 12:04 PM UTC
M
SBFM Receives Approval
Sunshine Biopharma receives Canadian regulatory approval for generic Arimidex
EQUITY | Jun 25, 2026, 12:01 PM UTC